Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Active, Not Recruiting
Checked: April 5, 2026 at 5:54 PM UTC
| NCT Number | NCT05520567 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | March 4, 2026 (Mar 4, 2026) |
As of April 5, 2026: Clinical trial NCT05520567 is currently active_not_recruiting participants. This clinical trial study for acute myeloid leukemia is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05520567 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05520567 was last updated Mar 4, 2026 (March 4, 2026). HelloStudys verifies this status automatically.